Ganga Pharmaceuticals

Ganga Pharmaceuticals

14.60
0.00
(0.00%)
Market Cap
9.90 Cr
EPS
0.16
PE Ratio
488.20
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
19.65
52 Week Low
9.25
PB Ratio
1.10
Debt to Equity
0.25
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,638.90
#1 3,93,227.01
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.35
6,158.50
1,63,488.82
69.37
9,712.00
18.67
2,191
26.74
35.29
1,589.80
1,28,409.39
23.86
28,409.50
7.12
5,291
9.88
66.07
3,657.30
1,23,779.65
61.13
11,539.40
6.99
1,911
19.91
59.05
2,598.00
1,07,226.93
56.78
12,744.20
#1 20.90
2,007
-18.14
60.15
1,271.50
1,06,115.71
#1 18.75
33,741.20
16.73
5,725
1.26
57.30
992.70
99,888.85
21.29
23,511.00
18.55
4,615
2.60
56.17
1,970.50
89,991.84
24.22
22,909.50
13.74
3,306
#1 51.64
53.40
32,685.00
69,453.34
47.71
6,684.70
9.64
1,414
11.55
44.46
5,449.00
65,150.97
28.51
13,458.30
3.70
2,216
21.39
70.65
Forecast
Actual
Growth Rate
Revenue Growth
3.45 %
Net Income Growth
18.60 %
Cash Flow Change
-3,050.00 %
ROE
-8.33 %
ROCE
-17.78 %
EBITDA Margin (Avg.)
-4.86 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
3
3
3
3
4
3
3
3
3
3
3
2
Expenses
2
2
3
3
3
3
2
2
3
3
3
1
EBITDA
0
0
1
1
1
1
0
0
0
0
-0
0
Operating Profit %
9 %
12 %
10 %
11 %
12 %
13 %
1 %
2 %
0 %
2 %
-4 %
-2 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
0
0
0
0
0
0
0
0
0
0
0
EPS in ₹
0.00
0.12
0.18
0.23
0.46
0.46
0.05
0.09
0.10
0.11
0.16
0.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
5
7
8
8
8
8
8
8
8
9
9
Fixed Assets
1
1
1
1
1
1
1
1
1
1
1
Current Assets
2
5
4
5
4
4
5
5
5
6
7
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
1
Other Assets
5
7
7
7
7
7
7
7
7
8
0
Total Liabilities
5
7
8
8
8
8
8
8
8
9
9
Current Liabilities
1
1
2
2
2
2
2
2
2
1
2
Non Current Liabilities
2
1
1
1
1
1
1
1
1
0
0
Total Equity
3
5
5
5
5
5
5
5
6
7
7
Reserve & Surplus
0
1
1
1
1
1
1
1
1
2
2
Share Capital
2
4
4
4
4
4
4
4
4
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
-0
-0
-0
0
0
0
0
Investing Activities
-0
-1
1
-0
0
0
0
0
1
0
Operating Activities
0
-1
0
0
0
-0
-0
-0
0
-1
Financing Activities
-0
2
-0
-0
-0
-0
-0
0
-0
1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Mar 2023
Sept 2023
Dec 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Jul 2025
Promoter
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
66.71 %
56.02 %
56.02 %
56.02 %
56.02 %
50.91 %
50.91 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
32.11 %
32.11 %
32.30 %
32.30 %
32.50 %
32.30 %
31.91 %
31.91 %
31.91 %
35.23 %
35.40 %
35.23 %
35.07 %
35.46 %
35.46 %
Others
1.18 %
1.18 %
0.98 %
0.98 %
0.79 %
0.98 %
1.38 %
1.38 %
1.38 %
8.75 %
8.58 %
8.75 %
8.91 %
13.63 %
13.63 %
No of Share Holders
354
354
354
354
356
356
355
356
359
362
363
365
368
367
367

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
20 Sept 2025 14.60 14.60
04 Jan 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
04 Jan 2024 14.36 27.10
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 24.67 19.57
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 15.73 15.73
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 13.51 13.51

Announcements

Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s1 day ago
Corporate Action - Fixes Book Closure For (AGM)1 day ago
Intimation For 36Th Annual General Meeting Scheduled To Be Held On Saturday September 20 2025.1 day ago
Board Meeting Outcome for Held On Wednesday August 20 20251 day ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 05, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 05, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 30, 2025
Non -Exercise Of Option To Convert Of Warrants.Jul 19, 2025
Announcement under Regulation 30 (LODR)-AllotmentJul 17, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Appointment of Company Secretary and Compliance OfficerJul 01, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Statement Of Deviation And VariationMay 20, 2025
ResultsMay 20, 2025
Board Meeting Outcome for Held On May 20 2025May 20, 2025
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Half And Financial Year Ended On March 31 2025.May 06, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 22, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 27, 2025
Board Meeting Outcome for Held On Thursday March 27 2025Mar 27, 2025
Closure of Trading WindowMar 26, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Statement Of Deviation For September 30, 2024Nov 08, 2024
Un-Audited Financial Results Of The Company For The HalfYear Ended On September 30, 2024.Nov 08, 2024
Board Meeting Outcome for For The Meeting Held On Friday, November 08, 2024Nov 08, 2024
Board Meeting Intimation For Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024Nov 06, 2024
Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results Of The Company For The Half Year Ended On September 30,2024Nov 05, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Closure of Trading WindowSep 26, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 25, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Reg. 34 (1) Annual Report.Sep 02, 2024
Notice Of The 35Th Annual General Meeting Of The CompanySep 02, 2024
Book Closure For The Purpose Of 35Th AGM 2024Aug 07, 2024
Intimation For 35Th Annual General Meeting Scheduled To Be Held On Wednesday, September 25, 2024Aug 07, 2024
Board Meeting Outcome for For The Meeting Held On Wednesday, August 07, 2024Aug 07, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 04, 2024
Submission Of Revised Audited Financial Results For The Half And Financial Year Ended March 31, 2024.Jun 17, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationMay 16, 2024
Statement Of Deviation For March 31, 2024May 16, 2024
Board Meeting Outcome for Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.May 16, 2024
Audited Financial Results Of The Company For The Half And Financial Year Ended On March 31, 2024.May 16, 2024
Board Meeting Intimation for To Inter Alia, Consider And Approve The Audited Financial Results Of The Company For The Half And Financial Year Ended March 31, 2024.May 06, 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 25, 2024
Submission Of Certificate Under Clause 40(10) Of SEBI (LODR) Regulation, 2015 For The Year Ended On March 31, 2024Apr 11, 2024

Technical Indicators

RSI(14)
Neutral
48.69
ATR(14)
Less Volatile
1.71
STOCH(9,6)
Neutral
76.91
STOCH RSI(14)
Overbought
92.82
MACD(12,26)
Bullish
0.46
ADX(14)
Strong Trend
38.97
UO(9)
Bearish
69.82
ROC(12)
Uptrend And Accelerating
6.96
WillR(14)
Neutral
-30.97